GlassScriptPhysician profile
Kelli Kennedy
NPI 1710567854
$926.33
in general payments reported to CMS, 2019-2025
16 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.29 · 2022: $152 · 2023: $23.62 · 2024: $510 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $362.29 | 2024-2025 | Indigo System |
| Medtronic, INC. | $118.10 | 2024 | Abre |
| Nevro Corp. | $72.73 | 2024 | Senza |
| Aurinia Pharma U.S., INC. | $64.57 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.48 | 2022 | |
| Merck Sharp & Dohme LLC | $43.63 | 2024 | Lynparza, Keytruda |
| Organogenesis INC. | $38.08 | 2024 | Affinity |
| Globus Medical, INC. | $36.46 | 2025 | Senza |
| Amgen INC. | $23.62 | 2023 | Tavneos |
| Actelion Pharmaceuticals US, INC. | $23.38 | 2022 | |
| Trisalus Life Sciences, INC. | $19.70 | 2024 | Trinav Infusion System |
| Janssen Biotech, INC. | $18.46 | 2022 | |
| Smith+Nephew, INC. | $17.03 | 2024 | Collagenase Santyl |
| Intercept Pharmaceuticals, INC. | $16.62 | 2021 | |
| Pharmacosmos Therapeutics INC. | $15.32 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $9.86 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.